Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

    Stock Recap
    #PipelineProspector

    Menu

    Amlodipine Besylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 94Xls

    Filters

    clear-filterReset all filters

    PRINCIPAL DISPLAY PANEL - 14 mg/10 mg Tablet Bottle Label

    TABLET;ORAL - EQ 10MG BASE;14MG

    PRINCIPAL DISPLAY PANEL - 7 mg/5 mg Tablet Bottle Label

    TABLET;ORAL - EQ 5MG BASE;7MG

    PRINCIPAL DISPLAY PANEL - 3.5 mg/2.5 mg Tablet Bottle Label

    TABLET;ORAL - EQ 2.5MG BASE;3.5MG

    PRINCIPAL DISPLAY PANEL Package Label – 10 mg / 320 mg / 25 mg Rx Only NDC 0781-5794-31 AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE TABLETS 10 mg* / 320 mg / 25 mg *each tablet contains 13.9 mg of amlodipine besylate 30 Tablets

    TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG

    PRINCIPAL DISPLAY PANEL Package Label – 10 mg / 320 mg / 25 mg Rx Only NDC 0781-5794-31 AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE TABLETS 10 mg* / 320 mg / 25 mg *each tablet contains 13.9 mg of amlodipine besylate 30 Tablets

    TABLET;ORAL - EQ 10MG BASE;25MG;160MG

    PRINCIPAL DISPLAY PANEL Package Label – 10 mg / 320 mg / 25 mg Rx Only NDC 0781-5794-31 AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE TABLETS 10 mg* / 320 mg / 25 mg *each tablet contains 13.9 mg of amlodipine besylate 30 Tablets

    TABLET;ORAL - EQ 10MG BASE;25MG;320MG

    PRINCIPAL DISPLAY PANEL Package Label – 10 mg / 320 mg / 25 mg Rx Only NDC 0781-5794-31 AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE TABLETS 10 mg* / 320 mg / 25 mg *each tablet contains 13.9 mg of amlodipine besylate 30 Tablets

    TABLET;ORAL - EQ 5MG BASE;25MG;160MG

    PRINCIPAL DISPLAY PANEL Package Label – 10 mg / 160 mg / 25 mg Rx Only NDC 0781-5787-31 AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE TABLETS 10 mg* / 160 mg / 25 mg *each tablet contains 13.9 mg of amlodipine besylate 30 Tablets

    TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG

    Amlodipine and Valsartan Tablets 10mg/320mg label

    TABLET;ORAL - EQ 10MG BASE;160MG

    Amlodipine and Valsartan Tablets 10mg/320mg label

    TABLET;ORAL - EQ 10MG BASE;320MG

    Amlodipine and Valsartan Tablets 10mg/320mg label

    TABLET;ORAL - EQ 5MG BASE;320MG

    Amlodipine and Valsartan Tablets 5mg/320mg label

    TABLET;ORAL - EQ 5MG BASE;160MG

    PRINCIPAL DISPLAY PANEL - 10 mg / 200 mg Tablet Bottle Label

    TABLET;ORAL - EQ 10MG BASE;200MG

    PRINCIPAL DISPLAY PANEL - 10 mg / 200 mg Tablet Bottle Label

    TABLET;ORAL - EQ 2.5MG BASE;200MG

    PRINCIPAL DISPLAY PANEL - 10 mg / 200 mg Tablet Bottle Label

    TABLET;ORAL - EQ 5MG BASE;200MG

    NDC 0597-0127-37

    TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    NDC 0597-0127-37

    TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    NDC 0597-0127-37

    TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    NDC 0597-0126-37

    TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    PRINCIPAL DISPLAY PANEL - Package Label – 10 mg/ 40 mg\n

    CAPSULE;ORAL - EQ 10MG BASE;20MG

    PRINCIPAL DISPLAY PANEL - Package Label – 10 mg/ 40 mg\n

    CAPSULE;ORAL - EQ 10MG BASE;40MG

    PRINCIPAL DISPLAY PANEL - Package Label – 10 mg/ 40 mg\n

    CAPSULE;ORAL - EQ 2.5MG BASE;10MG

    PRINCIPAL DISPLAY PANEL - Package Label – 10 mg/ 40 mg\n

    CAPSULE;ORAL - EQ 5MG BASE;10MG

    PRINCIPAL DISPLAY PANEL - Package Label – 10 mg/ 40 mg\n

    CAPSULE;ORAL - EQ 5MG BASE;40MG

    PRINCIPAL DISPLAY PANEL - Package Label – 10 mg/ 20 mg

    CAPSULE;ORAL - EQ 5MG BASE;20MG

    PRINCIPAL DISPLAY PANEL NDC 57664-775-83 Amlodipine and Olmesartan Medoxomil Tablets 10 mg*/ 40 mg *Each tablet contains 13.9 mg of amlodipine besylate 30 Tablets Rx Only

    TABLET;ORAL - EQ 10MG BASE;20MG

    PRINCIPAL DISPLAY PANEL NDC 57664-775-83 Amlodipine and Olmesartan Medoxomil Tablets 10 mg*/ 40 mg *Each tablet contains 13.9 mg of amlodipine besylate 30 Tablets Rx Only

    TABLET;ORAL - EQ 10MG BASE;40MG

    PRINCIPAL DISPLAY PANEL NDC 57664-775-83 Amlodipine and Olmesartan Medoxomil Tablets 10 mg*/ 40 mg *Each tablet contains 13.9 mg of amlodipine besylate 30 Tablets Rx Only

    TABLET;ORAL - EQ 5MG BASE;40MG

    PRINCIPAL DISPLAY PANEL NDC 57664-773-99 Amlodipine and Olmesartan Medoxomil Tablets 10 mg*/ 20 mg *Each tablet contains 13.9 mg of amlodipine besylate 90 Tablets Rx Only

    TABLET;ORAL - EQ 5MG BASE;20MG

    PRINCIPAL DISPLAY PANEL - 10 mg/80 mg Tablet Label

    TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE

    PRINCIPAL DISPLAY PANEL - 10 mg/80 mg Tablet Label

    TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE

    PRINCIPAL DISPLAY PANEL - 10 mg/80 mg Tablet Label

    TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE

    PRINCIPAL DISPLAY PANEL - 10 mg/80 mg Tablet Label

    TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE

    PRINCIPAL DISPLAY PANEL - 10 mg/80 mg Tablet Label

    TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE

    PRINCIPAL DISPLAY PANEL - 10 mg/80 mg Tablet Label

    TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE

    PRINCIPAL DISPLAY PANEL - 10 mg/80 mg Tablet Label

    TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE

    PRINCIPAL DISPLAY PANEL - 10 mg/40 mg Tablet Label

    TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE

    PRINCIPAL DISPLAY PANEL - 10 mg/40 mg Tablet Label

    TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE

    PRINCIPAL DISPLAY PANEL - 10 mg/20 mg Tablet Label

    TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE

    PRINCIPAL DISPLAY PANEL - 10 mg/20 mg Tablet Label

    TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE

    PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label

    TABLET;ORAL - EQ 10MG BASE

    PRINCIPAL DISPLAY PANEL - 5 mg Tablet Bottle Label

    TABLET;ORAL - EQ 5MG BASE

    PRINCIPAL DISPLAY PANEL - 2.5 mg Tablet Bottle Label

    TABLET;ORAL - EQ 2.5MG BASE

    X
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.